Norwegian diagnostics company Genetic Analysis is launching its GA-map Dysbiosis Test at the Centre for Digestive Diseases in Sydney, marking the company’s first installation of the technology in Australia. The company states this in a press release.The test is used to analyze deviations in the gut microbiome and is intended to support the assessment of patients with, among other conditions, IBS and inflammatory bowel disease. The launch is part of Genetic Analysis’ international expansion.